Users Coming Off Slimming Injections Gain Back Pounds Far More Rapidly Than Dieters

Fresh analysis suggests that patients who stop using blockbuster weight-loss injections like Mounjaro or Wegovy can put back on lost weight much more quickly than those who halt traditional diet and exercise regimens.

Published data in a leading health publication shows that while overweight individuals often shed about a fifth of their body weight while undergoing treatment, the weight is regained at an estimated rate of 0.8 kg per month upon discontinuation.

"Individuals purchasing such medications should be informed of the potential of rapid rebound weight gain when the therapy ends," stated expert Dr. Susan Jebb.

That rate of regain implies a return to original mass in about a year and a half.

Comparing Approaches

The study, which reviewed dozens of trials involving thousands of patients, contrasted the outcomes of these new drugs with older methods.

Researchers note that people who shed pounds through lifestyle changes alone typically have a more gradual weight regain—around 100 grams monthly—after stopping.

The Reason for the Rapid Rebound

Nutrition scientists believe the mode of action of the drugs accounts for the amplified regain.

These medications imitate a body's own chemical called glucagon-like peptide-1, which controls feelings of fullness.

"Artificially providing GLP-1 concentrations far above than normal could lead to the body to produce less of its endogenous hormone, and may also lessen sensitivity to its effects," noted Dr. Adam Collins, a dietetics expert.

"Withdrawal of this hormone supplement leads to appetite is unsuppressed, making binge eating much more probable."

An Ongoing Issue?

Health authorities advise the jabs for individuals with obesity-related health risks, alongside recommended lifestyle changes.

A number of clinicians say that, given the high risk of weight regain, the therapy might need to be life-long.

This opinion is reinforced by pharmaceutical companies, who state that the results "highlight the long-term nature of obesity," comparing it to managing diseases like hypertension.

Patient Testimonies

People who have stopped the medication explain a intense resurgence of appetite.

"It was like a switch activating and I was suddenly ravenous," recalled one woman.

This difficulty is worsened if users have not adopted lasting lifestyle or habit modifications during therapy.

Significant Interest

Survey data show that millions of people in the UK have tried weight-loss jabs in the past year, with interest being substantial.

• Adoption is greater among females compared to men.
• The middle-aged demographic shows the greatest usage rates.
• Many obtain the drugs through private prescriptions rather than the NHS.

Ultimately, experts caution that while GLP-1 drugs are effective agents for shedding pounds, they are not a magic cure and maintained weight loss relies on combined lifestyle changes.